Christal M.M. Mickle, M.A.

Christal M.M. Mickle, M.A.

Former Interim Chief Executive OfficeratZevra Therapeutics· In the 2023 proxy

Pay in FY2023Zevra Therapeutics stock +42.7% the same year

Christal M.M. Mickle, M.A. was paid $1.7M in FY2023 (Dec). Zevra Therapeutics stock rose 42.7% that year.

Pay$100 in the stock at the end of FY22 → $143
Pay is from the Summary Compensation Table of each Zevra Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Zevra TherapeuticsPublic company · 3 yr
    • Former Interim Chief Executive Officer2023 – Present · 3 yrStock in role +150%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?